Alexandria Real Estate Equities
Alexandria Real Estate Seeks Major Office Expansion in San Francisco’s Mission Bay
Life sciences developer requests over 500,000 square feet in office allocation as demand from AI firms reshapes district’s tenant mix San Francisco’s Planning...
Alexandria Lists for Sale 61,500 SQFT Life Science Building in Palo Alto
By The Registry Staff A life science property in Palo Alto could soon have a new owner. According to a marketing brochure from...
Alexandria Real Estate Posts Third Consecutive Quarterly Loss as Life Science Sector Challenges Persist
Life science REIT reports continued losses but maintains operational stability amid industry headwinds Alexandria Real Estate Equities (NYSE: ARE) reported its second quarter...
San Bruno Opens Public Review for Alexandria’s Massive Tanforan Mall Redevelopment
Alexandria Real Estate Equities seeks approval for mixed-use development to replace aging shopping center The City of San Bruno has officially launched the...
Cargo Therapeutics Vacates Nearly 100,000 SQFT Lease at Alexandria Center for Life Science in San Carlos
By The Registry Staff The Bay Area’s life science sector continues to see significant shifts with Cargo Therapeutics Inc. vacating its nearly 100,000...
Blox Ventures Acquires 100,000 SQFT R&D Campus in Mountain View for $11MM from Alexandria
(EDITOR’S NOTE: According to public documents from Alexandria Real Estate Equities, the property seller was the Pasadena-based life science REIT, and the sale...
Alexandria Real Estate Completes 290,000 SQFT Life Sciences Campus in Millbrae
290,000-square-foot facility represents first phase of larger transit-oriented development Alexandria Real Estate Equities has completed construction of a 290,000-square-foot life sciences campus at...
Strada Seeks to Transform Troubled Central SoMa Office Project at 88 Bluxome Into 1,500-Unit Residential Complex
San Francisco-based Strada Investment Group submits ambitious housing proposal for Alexandria Real Estate’s long-stalled 88 Bluxome development A San Francisco development firm has...
Life Science Reality Check: Alexandria’s Q1 Performance Reflects Industry Challenges Despite Executive Optimism
Alexandria Real Estate Equities (ARE), a pure-play life science REIT, reported its Q1 2025 earnings on April 29th with mixed results that suggest...
Alexandria Real Estate Plans an Accelerated Disposition Strategy for 2025
Alexandria Real Estate Equities, Inc. (NYSE: ARE) is executing an ambitious disposition strategy in 2025 as it faces headwinds in the life science...
San Francisco Bay Area Poised for Continued Life Sciences Expansion in 2025
The San Francisco Bay Area remains one of the most dynamic life sciences markets in the United States, bolstered by strong institutional backing,...
Alexandria Presents More Details on 3MM SQFT Tanforan Mall Redevelopment in San Bruno
By Kate Snyder As the Bay Area continues to grapple with ways to bring needed housing to its communities, a significant project is...
